Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 16, 2020 - Issue
Submit an article Journal homepage
172
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma

Rong-yun Mai1 Department of Hepatobilliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;2 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2768-6391View further author information
ORCID Icon,
Jie Zeng2 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4964-8030View further author information
ORCID Icon,
Yi-shuai Mo1 Department of Hepatobilliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaView further author information
,
Rong Liang3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of China;4 Department of First Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5209-9426View further author information
ORCID Icon,
Yan Lin3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of China;4 Department of First Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of ChinaView further author information
,
Su-su Wu2 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaView further author information
,
Xue-min Piao2 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of China;4 Department of First Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of ChinaView further author information
,
Xing Gao2 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of China;4 Department of First Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of ChinaView further author information
,
Guo-bin Wu1 Department of Hepatobilliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0505-9637View further author information
ORCID Icon,
Le-qun Li1 Department of Hepatobilliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3224-4918View further author information
ORCID Icon &
Jia-zhou Ye1 Department of Hepatobilliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning530021, People’s Republic of China;3 Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning530021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 639-649 | Published online: 17 Jul 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yakup Ülger & Anıl Delik. (2023) Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: genetic based artificial neural networks. Nucleosides, Nucleotides & Nucleic Acids 42:5, pages 398-406.
Read now

Articles from other publishers (6)

Yixin Hou, Hao Yu, Qun Zhang, Yuying Yang, Xiaoli Liu, Xianbo Wang & Yuyong Jiang. (2023) Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients. Diagnostic Pathology 18:1.
Crossref
Dillip Kumar Bishi, Priyadarshini Padhi, Chhabi Rani Panigrahi, Bibudhendu Pati & Chandi Charan Rath. 2023. Computational Intelligence in Cancer Diagnosis. Computational Intelligence in Cancer Diagnosis 317 336 .
Min Chen, Guang-Bo Wu, Zhi-Wen Xie, Dan-Li Shi & Meng Luo. (2022) A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening. Frontiers in Genetics 13.
Crossref
Xiaoqin Lai, Wenfa Chen, Yuzhu Wu, Yali Gao, Yalan Zhang, Xuwei Xu, Ya Fu, Xinwen Wang, Yanbing Yang & Yin Zhang. (2022) Effect of mutations across reverse transcriptase region on HBV replication and progression of liver diseases in Chinese patients . Journal of Clinical Laboratory Analysis 36:7.
Crossref
Rong-yun Mai, Jie Zeng, Wei-da Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guo-bin Wu, Le-qun Li, Liang Ma, Jia-zhou Ye & Tao Bai. (2021) Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion. BMC Cancer 21:1.
Crossref
Rukayya Umar, Steve Adeshina & Moussa mahamat Boukar. (2021) Performance Evaluation of Machine Learning Approach for hepatitis Classification with genetic Algorithm feature Selection. Performance Evaluation of Machine Learning Approach for hepatitis Classification with genetic Algorithm feature Selection.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.